Accent Microcell Ltd.

NSE : ACCENTMICSM BSE : ISIN CODE : INE0Q5D01013Industry : Pharmaceuticals

371.158.70
(2.40%)

27 Mar 2026 | 03:59

Open (Rs.)

360.00

Prev. close (Rs.)

362.45

Bid Price(Qty.)

371.15(500)

Offer Pr.(Qty.)

0.00(0)

Volume (Rs.)

53000.00

Today's High / Low

380.00

359.95

52 Week High / Low

380.00

174.47

Company Info

Management

Mr. Vasant PatelChairman & Executive Director
Mr. Ghanshyam PatelManaging Director & CFO
Mr. Nitin PatelExecutive Director
Mr. Vinod PatelExecutive Director
Ms. Shreya ShahIndependent Director

Incorporation Year

10/04/2012

Registered Address

Registered Office : 314, Shangrilla Arcade, Shyamal Cross Road, , Anandnagar Road,Satellite,
Ahmedabad, Gujarat - 380015
Tel: Tel: 079-40042367
Fax:
Email : cs@accentmicrocell.com
Website : http://www.accentmicrocell.com

Registrar Office

KFin Technologies Ltd.
Selenium Tower B, Plot No. 31-32,
Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad - 500032Tel: 040-67161500
Fax: 23420814

Listing

NSE , NSE

Financials

Owners Fund (₹ Cr.)

Net Block (₹ Cr.)

Curr. Assets (₹ Cr.)

Investments (₹ Cr.)

Note: Values are based on Consolidated Data

Shareholding Pattern

News

Please Login to view Research & Trading Ideas

Emkay Trading Ideas

Please Login to view Research & Trading Ideas

Peer Comparison

Company Name	Price ( ₹ )	Book Value ( ₹ )	EPS ( ₹ )	Market Cap. (₹ Cr.)	P/E (x)	Year End	Sales (₹ Cr.)	PAT (₹ Cr.)
+ Aarey Drugs & Pharmaceut...	55.90	52.66	1.42	158.50	39.39	202503	473.94	4.02
+ Aarti Drugs Ltd.	330.70	165.32	18.42	3,018.30	17.95	202503	2,387.03	168.16
+ Aarti Pharmalabs Ltd.	608.85	230.45	30.05	5,519.70	20.26	202503	2,115.07	272.40
+ Abbott India Ltd.	26,135.00	2,064.48	665.64	55,535.05	39.26	202503	6,409.15	1,414.44
+ Accent Microcell Ltd.	371.15	104.07	13.78	890.35	26.93	202503	264.58	33.06

MF Holding

No Data Available

Individual Holding

Date of Meeting	Purpose
14/10/2025	Quarterly Results & Others
22/08/2025	Dividend & Others
29/05/2025	To Consider Fund Raising & Other
09/05/2025	Audited Results & Others
29/10/2024	To Consider Fund Raising